Visit http://invest.trueleaf.com and click the “Invest Now” button in the navigation bar. Please make sure to read the offering circular herewhich details all the terms of this offering, before making an investment.
You are investing in True Leaf Medicine International Ltd. True Leaf Pet and True Leaf Medicine are two subsidiaries of the Canadian-based health and wellness company. While True Leaf Pet is dedicated to developing functional hemp-based pet products, True Leaf Medicine is a licensed producer applicant and has reached the final stage of becoming a supplier of medicinal cannabis products for both people and pets under the Canadian government’s legal Access to Cannabis for Medicinal Purposes Regulations (ACMPR).
True Leaf is looking to raise $10 million. The funds will be used to grow the revenue of its subsidiary True Leaf Pet, and to advance the efforts of its subsidiary True Leaf Medicine to become a licensed producer of medicinal cannabis in Canada.
Canadian and US residents can invest! True Leaf is selling securities in the United States relying on Tier 2 of Regulation A under the Securities Act of 1933. In Canada, True Leaf relies on the offering memorandum exemption under National Instrument 45-106.
True Leaf is the first cannabis-related public company to apply for Regulation A+ crowdfunding in the USA as of September 2017. True Leaf Medicine International Ltd. is publicly traded on Canada’s CSE, Germany’s FSE, and USA’s OTCQB.
The cannabis industry is a very dynamic industry that is garnering lots of attention from clients, investors, media and governments. In the US, cannabis remains federally illegal. In Canada, the federal government is planning to legalize marijuana in 2018. True Leaf sells legal hemp pet products in the US, Canada and globally. In Canada we are in the final phase of being approved as a licensed provider of medical marijuana.
The Securities and Exchange Commission (SEC) exists to protect investors and promote a market environment that is worthy of the public's trust. True Leaf has applied and met the stringent requirements of the SEC. We are proud the SEC has approved our Reg A+ offering and views this decision as an endorsement of the quality of our management and integrity of our company and product.
True Leaf is currently in the build out phase of the process to acquire a license to produce marijuana in Canada under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Once True Leaf successfully completes construction, the company can expect to be granted a license to cultivate cannabis and produce marijuana in Canada. Health Canada will then schedule an inspection to verify that True Leaf is meeting the requirements of the ACMPR, and if the company successfully completes that step, Health Canada will issue a license for True Leaf to sell cannabis products in Canada. The company filed an application in 2013 under the Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
The Jumpstart Our Business Startups (JOBS) Act was signed into law by President Barack Obama on April 5, 2012, to encourage funding of small businesses by easing various securities regulations. The JOBS Act required the Securities and Exchange Commission (SEC) to adopt rules to implement a new exemption that would allow businesses to accept contributions from private individuals without making an initial public offering.
In June 2015, the final "Regulation A+" rules under Title IV of the JOBS Act became effective, after approval by the SEC, paving the way for companies like True Leaf to solicit their raise up to $50 million from both accredited and non-accredited investors.
"The SEC has qualified this offering" means the SEC has permitted True Leaf to offer for sale the securities described in the offering circularhere to investors such as you. The SEC is not judging the merits, accuracy, or completeness of the offering and information in the offering circular. Rather, the SEC is merely ensuring True Leaf has met federal legal disclosure and regulatory requirements necessary to make these shares available to you.
An accredited investor is an individual who makes over $200,000 per year ($300,000 if combined with a spouse) or who has a net worth of $1 million or more, excluding their primary residence. A non-accredited investor is anyone who does not meet the net worth requirements for an accredited investor.
This Presentation (the “Presentation”) has been prepared solely for informational purposes by True Leaf Medicine International Ltd. (“True Leaf”) and is being furnished through Boustead Securities, LLC (“Boustead Securities”) solely for use by prospective investors and other third parties in connection with their consideration of an investment in True Leaf. This presentation is not, and should not be assumed to be, complete. This presentation has been prepared to assist interested parties in making their own evaluation of True Leaf and does not purport to contain all of the information that may be relevant. In all cases, interested parties should conduct their own investigation and analysis of True Leaf and the data set forth in this presentation and other information provided by or on behalf of True Leaf. Any views and opinions expressed in this presentation are those of True Leaf and do not necessarily represent facts. In addition, certain of the information contained herein may be derived from information provided by industry sources. True Leaf believes that such information is accurate and that the sources from which it has been obtained are reliable. True Leaf cannot guarantee the accuracy of such information, however, and has not independently verified such information. The information presented herein remains subject to change. Statements in this presentation are made as of the date of this presentation unless stated otherwise.
SEC Disclaimer: An offering statement regarding this offering has been filed with the SEC. The SEC has qualified that offering statement which only means that True Leaf Medicine Inc. may make sales of the securities described by that offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement here. You should read the offering circular before making any investment.
Forward-Looking Statements: This presentation also contains statements that, to the extent they are not recitations of historical fact, constitute “forward-looking statements.” Forward-looking statements are typically identified by the use of terms such as “may,” “should,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate," “believe,” “continue,” “predict,” “potential” or the negative of such terms and other comparable terminology. The forward-looking statements included herein are based upon True Leaf’s current expectations, plans, estimates, assumptions and beliefs that involve numerous risks and uncertainties. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond True Leaf’ control. Although True Leaf believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, True Leaf’ actual results and performance and the value of its securities could differ materially from those set forth in the forward-looking statements due to the impact of many factors including, but not limited to, risks and uncertainties detailed in the “Risk Factors” in the Risk Factors section of True Leaf’ Offering Circular on Form 1-A, filed with the U.S. Securities and Exchange Commission and other discussions of risk factors contained in True Leaf’s periodic filings or supplements to the offering circular. True Leaf Offering Circular on Form 1-A can be found at https://www.trueleaf.com/pages/investor. True Leaf claims the safe harbor protection for forward looking statements contained in the Private Securities Litigation Reform Act of 1995. True Leaf undertakes no obligation to update or revise any such information for any reason after the date of this presentation, unless required by law.
Investment in True Leaf’s securities involves significant risks. You should purchase these securities only if you can afford a complete loss of your investment.